Company Filing History:
Years Active: 2006-2009
Title: Katarina Beierlien: Innovator in Sulfonamide Compounds
Introduction
Katarina Beierlien is a prominent inventor based in Uppsala, Sweden. She has made significant contributions to the field of medicinal chemistry, particularly in the development of sulfonamide compounds. With a total of 2 patents, her work focuses on addressing critical medical conditions.
Latest Patents
Katarina's latest patents include innovative compounds that have potential applications in treating obesity, type II diabetes, and disorders of the central nervous system. The first patent, titled "Substituted Naphthalene Sulfonamides," relates to sulfonamide compounds of a specific general formula. These compounds are designed to be useful in the prophylaxis and treatment of various medical conditions. The second patent, "Bicyclic Sulfonamide Compounds," similarly focuses on substituted sulfonamide compounds with the same potential applications.
Career Highlights
Katarina Beierlien is currently associated with Biovitrum AB, a company known for its commitment to biopharmaceutical innovation. Her work at Biovitrum has allowed her to explore and develop new therapeutic solutions that can significantly impact patient care.
Collaborations
Katarina collaborates with esteemed colleagues such as Patrizia Caldirola and Ulf J Bremberg. These partnerships enhance her research and contribute to the advancement of her innovative projects.
Conclusion
Katarina Beierlien is a dedicated inventor whose work in sulfonamide compounds holds promise for the treatment of serious medical conditions. Her contributions to the field exemplify the importance of innovation in healthcare.